Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - ForteBio

  • Targeting Protein-Protein Interactions
    ... Novel Dip and Read Biosensor Launched ForteBio, a division of Pall Life Sciences, last ... For single-sample microvolume protein analysis, ForteBio recently launched the BLItz ...
    2-15-2013
  • Advertorial: Rapid Quantitation of Monoclonal Antibodies Using...
    ... Biosensor Selection A variety of biosensors are available from ForteBio for quantitation ... Users may choose IQ/OQ service be performed by ForteBio qualified service personnel, or by ...
    12-1-2012
  • Advertorial: Optimal Feed Strategies to Enhance Protein Production...
    ... Vi-Cell® automated cell counter (Trypan blue exclusion technique). [IgG] determined via biolayer interferometry on a ForteBIO Octet® QK 384 system (protein A based probes). ...
    12-1-2012
  • Pall to Take Over ForteBio for Protein Analysis Systems
    2012. Headquartered in Menlo Park, CA, ForteBio offers an array of innovative, ... are thrilled about the acquisition of ForteBio and the added value it enables Pall to ...
    12-19-2011
  • Getting Up to Speed on Label-Free Methods
    ... With the capability to integrate with widely used SPR-based instruments such as the Octet® (ForteBIO), BIND® (SRU Biosystems) and EPIC (Corning), or impedance-based instruments ...
    9-15-2011
  • Rapid Evaluation of Biosensor Chemistries
    for a quantitation assay on the ForteBio Octet instrument using a multi-analyte ... ForteBio currently offers six out-of-the-box biosensors for quantitation: protein A, ...
    5-15-2011
  • Rapid Identification of Production Strains
    Accelerating Protein Concentration and Functional Analyses to Improve Efficiency Figure 1. The Octet platform consists of Octet RED384 and QK384 systems that provide 16-channel ...
    6-15-2010
  • Fluidics-Free Molecular Interactions Analysis
    ForteBio's Dip and Read Method Simplifies Label-Free Assays Figure 1. Biolayer interferometry Molecular interactions play a myriad of important roles in drug discovery and ...
    7-1-2009
  • Determining Small Molecule Binding Kinetic Constants
    Determining and evaluating the affinity of small molecule binding to a therapeutic target is a major component of drug discovery and lead optimization. In a technical note entitled ...
    3-15-2009
  • Protein Analysis Technologies Overview
    ... targets in E. coli. Going Label-Free FortéBIO introduced the Octet RED System, a ... Joy Concepcion, product manager at FortéBIO, explained that the system can operate in two ...
    8-1-2008
  • Label-Free Biosensors Show Early Promise
    ... Are these really easy?" he asked. "But then, I suppose initial impressions take a long time to shake off in this business." Biolayer Interferometry The ForteBio (www.fortebio.com) ...
    2-15-2007
  • Antibody Engineering Methods Advance
    ... Lately a number of newly developed solutions for label-free detection of protein-protein interactions have been introduced to the market place. The ForteBio (www.fortebio.com) ...
    11-1-2006

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll